Research and Development

Showing 15 posts of 9600 posts found.

Pressure on pharma M&A

January 7, 2013 Research and Development, Sales and Marketing Ernst & Young, M&A, MA, mergers

The world’s largest pharma companies will be under greater pressure to merge with or purchase other firms over the next …
sarah_bater

Celgene appoints new Human Resources director

January 2, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

Celgene has announced the appointment of Sarah Bater as director of Human Resources, Celgene UK and Ireland. Bater brings a wealth …

Contract research news in brief

December 21, 2012 Research and Development Almac, Clinipace, Harrison Clinical Research, PRA, Quintiles, Synteract, WuXi PharmaTech

Synteract agrees to by Harrison Clinical Research, WuXi forges JV with PR, plus appointments and a new accreditation for Quintiles’ …

Merck KGaA pipeline hit

December 21, 2012 Research and Development, Sales and Marketing Cancer, Merck KGaA, NSCLC, pipeline

Merck KGaA’s pipeline has been dented by the ‘disappointing’ late-stage failure of Stimuvax in a programme with non-small cell lung …

Sanofi global operations president to retire

December 20, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanspeter Spek, Sanofi

Sanofi has announced that Hanspeter Spek, president, Global Operations, will retire from his current role in mid-2013. Christopher Viehbacher, chief executive …

Sanofi – aiming for number one in the world’s biggest diabetes market

December 18, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, Sanofi, diabetes, obesity

Sanofi is no different from any other major pharma company in seeing China as the single most important growth market …
haslam

David Haslam confirmed as NICE chair

December 18, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Haslam, Hunt, NICE

David Haslam has been confirmed as chair of the National Institute for Health and Clinical Excellence. Professor Haslam is currently …
eckert

Amgen appoints Mattel’s Robert Eckert to Board of directors

December 14, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Eckert

Biotech firm Amgen has announced the appointment of Robert Eckert, former chief executive officer at Mattel, to its Board of …
Astrazeneca image

RA setbacks for AstraZeneca and Lilly

December 14, 2012 Research and Development, Sales and Marketing AstraZeneca, Humira, RA, lilly

AstraZeneca and Eli Lilly have both suffered setbacks in their attempts to push their respective investigational rheumatoid arthritis (RA) treatments …
stack

David Stack appointed to Amarin Board of directors

December 14, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Amarin, David Stack

Biopharma firm Amarin has confirmed that David Stack, president and chief executive of Pacira Pharmaceuticals, has joined its Board of …

Hold tight: a bumpy ride ahead for the NHS

December 13, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hunt, Lansley, NHS, Wallards, reforms

The Wellards Annual Conference is an event where two worlds – the industry and the NHS – meet for a …
barbara_domayne-hayman

Stevenage Bioscience Catalyst hires first entrepreneur-in-residence

December 13, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Stevenage Bioscience Catalyst

Early-stage biotech firm Stevenage Bioscience Catalyst (SBC) has appointed Dr Barbara Domayne-Hayman as its first entrepreneur-in-residence. Domayne-Hayman will work with …
dr_jean-michel_cossery_photo

New managing director for Lilly UK

December 12, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing lilly

Lilly UK has appointed Dr Jean-Michel Cosséry as the new managing director and VP of the UK Affiliate and the …
charlie_morris

Almac Group appoints Charlie Morris to executive team

December 12, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almac Group

The Almac Group’s Clinical Technologies business unit has announced that Charlie Morris has joined the company as vice president of …
novartis_window

Novartis blood cancer hope

December 12, 2012 Research and Development, Sales and Marketing Jakavi, Novartis, oncology

Two-year data from Novartis’s drug Jakavi suggests that it may improve overall survival in a rare form of cancer versus …
The Gateway to Local Adoption Series

Latest content